1. Home
  2. BRO vs TEVA Comparison

BRO vs TEVA Comparison

Compare BRO & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brown & Brown Inc.

BRO

Brown & Brown Inc.

HOLD

Current Price

$79.94

Market Cap

27.6B

Sector

Finance

ML Signal

HOLD

Logo Teva Pharmaceutical Industries Limited

TEVA

Teva Pharmaceutical Industries Limited

HOLD

Current Price

$31.80

Market Cap

30.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRO
TEVA
Founded
1939
1901
Country
United States
Israel
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.6B
30.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BRO
TEVA
Price
$79.94
$31.80
Analyst Decision
Hold
Strong Buy
Analyst Count
14
9
Target Price
$97.93
$32.67
AVG Volume (30 Days)
2.6M
9.2M
Earning Date
01-26-2026
01-28-2026
Dividend Yield
0.83%
N/A
EPS Growth
N/A
N/A
EPS
3.31
0.62
Revenue
$5,350,000,000.00
$16,776,000,000.00
Revenue This Year
$27.48
$4.62
Revenue Next Year
$23.16
$0.34
P/E Ratio
$24.11
$52.42
Revenue Growth
17.50
0.02
52 Week Low
$76.17
$12.47
52 Week High
$125.68
$33.42

Technical Indicators

Market Signals
Indicator
BRO
TEVA
Relative Strength Index (RSI) 49.44 59.77
Support Level $78.54 $31.92
Resistance Level $80.42 $32.86
Average True Range (ATR) 1.77 0.74
MACD 0.04 -0.21
Stochastic Oscillator 64.35 43.90

Price Performance

Historical Comparison
BRO
TEVA

About BRO Brown & Brown Inc.

Brown & Brown Inc is a diversified insurance agency, wholesale brokerage, insurance programs, and service. The Company markets and sells insurance products and services, in the property, casualty, and employee benefits areas. It provides customers with non-investment insurance contracts, as well as other targeted, customized risk management products and services. It has four reportable segments; the Retail segment; the Programs segment; the Wholesale Brokerage segment and; the Services segment. It generates the majority of its revenue from the Retail segment which provides insurance products and services to commercial, public and quasi-public, and Others through automobile dealer services F&I businesses. Its geographic area is U.S., U.K., the Republic of Ireland, Canada, and Others.

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Share on Social Networks: